McKinsey beforehand paid $641.5 million to resolve claims by state attorneys basic and one other $230 million to resolve claims by native governments. It has additionally settled circumstances by Native American tribes.

Friday’s class motion settlement, which requires a decide’s approval, resolves claims by so-called third-party payers like insurers that present well being and welfare advantages.

Paul Geller, a lawyer for the plaintiffs, in an announcement stated the drug disaster was attributable to an oversupply of harmful addictive medicine, and the case aimed to “recover some of the money spent on the over-prescribed pills.”

McKinsey didn’t admit wrongdoing. In an announcement, the agency stated it continued to imagine its previous work was lawful. It additionally famous it had dedicated in 2019 to now not advise shoppers on any opioid-related enterprise.

Thousands of lawsuits have been filed by states, native governments and Native American tribes accusing drug corporations of downplaying the dangers of opioid painkillers, and distributors and pharmacies of ignoring crimson flags that they have been being trafficked illegally.

The litigation has resulted in additional than $50 billion in settlements with drugmakers, distributors and pharmacy chains.

Nearly 645,000 individuals died within the United States from overdoses involving opioids, each prescription and illicit, from 1999 to 2021, in keeping with the US Centers for Disease Control and Prevention.

The US Supreme Court earlier this month heard a problem by President Joe Biden’s administration to Purdue Pharma’s multi-billion-dollar chapter settlement resolving associated claims towards the drugmaker.